SCHEMBL715456

SCHEMBL715456

CCCCCCCCCOOOC(N)N

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DNM1 Q05193 1/20 0.41
CA1 P00915 9/20 0.38
CA2 P00918 9/20 0.38
CA9 Q16790 8/20 0.38
CA12 O43570 3/20 0.38
CA7 P43166 3/20 0.38
CA14 Q9ULX7 3/20 0.38
CA3 P07451 2/20 0.38
CA4 P22748 2/20 0.38
CA6 P23280 2/20 0.38
CA5A P35218 2/20 0.38
CA5B Q9Y2D0 2/20 0.38
HTT P42858 2/20 0.37
EPHX1 P07099 1/20 0.35
THRB P10828 2/20 0.35
TSHR P16473 1/20 0.35
OPRM1 P35372 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
MAPT P10636 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4216585 1.00 DNM1 (0.41) DNM1CA1CA2CA9CA12
SCHEMBL1809443 1.00 DNM1 (0.41) DNM1CA1CA2CA9CA12
SCHEMBL3455284 0.94 DNM1 (0.39) DNM1CA1CA2CA9CA12
SCHEMBL642173 0.86 DNM1 (0.43) DNM1CA1CA2CA9CA12
SCHEMBL7717593 0.86 DNM1 (0.43) DNM1CA1CA2CA9CA12
SCHEMBL31441390 0.86 DNM1 (0.43) DNM1CA1CA2CA9CA12
SCHEMBL4335355 0.84 DNM1 (0.40) DNM1CA1CA2CA9CA12
SCHEMBL17821233 0.78 THRB (0.50) CA1CA2CA9CA12CA7
SCHEMBL17821238 0.78 THRB (0.50) CA1CA2CA9CA12CA7
SCHEMBL17821232 0.78 THRB (0.50) CA1CA2CA9CA12CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 166 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260139097-A1 SELF-HEALING MULTI-COMPONENT POLYIMIDE COMPOSITION AND FILM, AND METHOD FOR MANUFACTURING THE SAME KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2026-05-21 US claimed
EP-4549620-A1 PROCESS FOR MAKING AMINES FROM NITRILE COMPOUNDS USING HYDROGEN HAVING LOW DEUTERIUM CONTENT PRODUCED WITH NON-FOSSIL ENERGY IN THE ABSENCE OF AMMONIA BASF SE (DE) 2025-05-07 EP claimed
EP-4549618-A1 PROCESS FOR MAKING AMINES FROM NITRILE COMPOUNDS USING HYDROGEN HAVING LOW DEUTERIUM CONTENT PRODUCED WITH NON-FOSSIL ENERGY BASF SE (DE) 2025-05-07 EP claimed
US-20250002651-A1 POLYETHERAMIDE SYNERGIST EVONIK OPERATIONS GMBH (DE) 2025-01-02 US claimed
EP-4484464-A1 POLYETHERAMIDE SYNERGIST Evonik Operations GmbH (DE) 2025-01-01 EP claimed
WO-2024116091-A1 A COMPOSITION, AN ARTICLE, METHODS OF PREPARATION AND APPLICATION THEREOF TATA STEEL LIMITED (IN) 2024-06-06 WO claimed
EP-3221414-B1 COLOR-CHANGING ADHESIVE COMPOSITION 3M INNOVATIVE PROPERTIES CO (US) 2021-06-02 EP claimed
CN-107001894-B Color-changing adhesive composition 3M创新有限公司 2021-01-12 CN claimed
EP-2559732-B1 Epoxy encapsulating and lamination adhesive and method of making same GEN ELECTRIC (US) 2017-04-26 EP claimed
EP-2196494-B1 Polyamide layer silicate compounds EMS PATENT AG (CH) 2014-03-26 EP claimed
US-8003705-B2 In situ formation of slowly biodegradable materials; reaction between precursors having electrophilic and nucleophilic functionality; enzymatic and hydrolysis resistance; controlled drug delivery agents, postoperative adhesion prevention, medical device coatings, wound dressings, surgical sealants; kits INCEPT LLC (US) 2011-08-23 US claimed
EP-2196193-A1 Hydrogels suitable for use in polyp removal Tyco Healthcare Group LP (US) 2010-06-16 EP claimed
EP-2196494-A1 Polyamide layer silicate compounds EMS-PATENT AG (CH) 2010-06-16 EP claimed
EP-2152831-A2 IMPROVED STRUCTURAL ADHESIVE MATERIALS Hexcel Composites Limited (GB) 2010-02-17 EP claimed
WO-2009031146-A1 HIGH REFRACTIVE INDEX, LOW VISCOSITY ROOM TEMPERATURE TWO-PART EPOXY RESINS MEMPILE INC. (US) 2009-03-12 WO claimed
WO-2008146014-A2 IMPROVED STRUCTURAL ADHESIVE MATERIALS HEXCEL COMPOSITES LIMITED (GB) 2008-12-04 WO claimed
US-20260139097-A1 SELF-HEALING MULTI-COMPONENT POLYIMIDE COMPOSITION AND FILM, AND METHOD FOR MANUFACTURING THE SAME KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2026-05-21 US disclosed
US-20260015532-A1 LOW-DENSITY POTTING ADHESIVE 3M INNOVATIVE PROPERTIES COMPANY (US) 2026-01-15 US disclosed
US-5539023-A EPOXIDE-POLYALKYLENE POLYETHERPOLYOL-AMINE ADDUCT HOECHST AKTIENGESELLSCHAFT (DE) 1996-07-23 US disclosed
EP-0610787-A2 Curing agents for aqueous epoxy resin dispersions HOECHST AKTIENGESELLSCHAFT (DE) 1994-08-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260015532-A1 LOW-DENSITY POTTING ADHESIVE ITGAM, ASH2L, ASH1L DNM1 3216/4885CA1 1622/4885CA2 2745/4885
US-20260139097-A1 SELF-HEALING MULTI-COMPONENT POLYIMIDE COMPOSITION AND FILM, AND METHOD FOR MANUFACTURING THE SAME SMCHD1, PDAP1, CAD DNM1 1407/4885CA1 2464/4885CA2 3647/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.